DSS, Inc. (DSS)
| Market Cap | 5.22M -41.3% |
| Revenue (ttm) | 20.76M +8.7% |
| Net Income | -23.93M |
| EPS | -2.66 |
| Shares Out | 10.04M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 56,601 |
| Open | 0.5200 |
| Previous Close | 0.5295 |
| Day's Range | 0.5200 - 0.5498 |
| 52-Week Range | 0.5100 - 1.8950 |
| Beta | 1.00 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | May 15, 2026 |
About DSS
DSS, Inc. operates in the product packaging, biotechnology, commercial lending, securities and investment management, and direct marketing businesses in the United States. The company manufactures, markets, and sells mailers, photo sleeves, custom folding cartons, and 3-dimensional direct mail solutions; and markets and distributes nutritional and personal care products. It invests in or acquires companies in the biohealth and biomedical fields, including businesses that focuses on the advancement of drug discovery and prevention, inhibition, a... [Read more]
Financial Performance
In 2025, DSS, Inc.'s revenue was $20.76 million, an increase of 8.69% compared to the previous year's $19.10 million. Losses were -$23.93 million, -48.97% less than in 2024.
Financial StatementsNews
DSS reports ‘going concern’ audit opinion in 2025 10-K filing
DSS (DSS) announced that its annual report for the fiscal year ending December 31, 2025, filed on March 31, 2026, includes an audit opinion from HTL International LLC. that contains…
DSS, Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing
ROCHESTER, N.Y., May 08, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS) announced that its annual report (10-K) for the fiscal year ending December 31, 2025, filed on March 31, 2026, includes...
DSS, Inc. Announces Closing of $1.0 Million Underwritten Public Offering
NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS) (the “Company”), a multinational company operating across diverse industries including product packaging, biotechnology, comm...
DSS prices 900,000 shares at $1.00 in underwritten public offering
DSS (DSS) announced the pricing of a firm commitment underwritten public offering with gross proceeds to the Company expected to be approximately $1M, before deducting underwriting fees and other offe...
DSS, Inc. Announces Pricing of $1.0 Million Underwritten Public Offering
NEW YORK, Feb. 04, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE: DSS) (the “Company”), a multinational company operating across diverse industries including product packaging, biotechnology, commercial le...
DSS, Inc. Announces Launch of Proposed Public Offering
NEW YORK, Feb. 03, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE: DSS) (the “Company”), a multinational company operating across diverse industries including packaging, wealth management, and biohealth inn...
DSS’ Impact BioMedical announces strategic merger with Dr. Ashley’s
DSS (DSS) announced that its subsidiary, Impact BioMedical, has entered into a definitive merger agreement with Dr. Ashleys. Under the terms of the agreement, Dr. Ashleys will acquire Impact through…
DSS, Inc. Reports Strong Q1 2025 Financial Performance, Setting the Stage for Strategic Growth
NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a multinational company operating across diverse industries including packaging, real estate, and biomedical innovation, toda...
DSS announces sale of Celios to Impact BioMedical
DSS (DSS) announced the sale of its Celios air purification asset to Impact BioMedical (IBO) in a strategic, all-equity transaction valued at approximately $1.15M. This divestiture aligns with DSS’ on...
DSS, Inc. Announces Sale of Celios® to Impact BioMedical, Streamlining Portfolio for Strategic Growth
ROCHESTER, N.Y., Feb. 26, 2025 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a multinational company focused on innovation-driven business models, today announced the sale of its Celios® air pur...
DSS interim CEO says immediate focus is to ‘optimize operational efficiencies’
DSS (DSS) issued the following letter to shareholders from interim CEO Jason Grady, which read in part, “As we embark on this new chapter, my immediate focus is to optimize…
DSS, Inc. Issues Letter to Shareholders
NEW YORK, Feb. 03, 2025 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS) a multinational company operating businesses within diversified market sectors that strategically acquires and develops asset...
LiveData PeriOp Manager Launched in 88 Veterans Affairs Hospitals
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- #DocumentStorageSystems--LiveData and DSS advance operating room efficiency and patient access to surgery across 85% of VA Medical Centers with LiveData PeriOp Mana...
DSS, Inc. Celebrates Impact BioMedical Inc.'s Successful IPO and Proudly Advances Shareholder Value
NEW YORK, Sept. 16, 2024 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a dedicated supporter and investor in Impact BioMedical Inc. (NYSE American: IBO), is delighted to announce the successful ...
AmericaFirst Funds Trust Announces Changes to Board of Trustees
NEW YORK, Sept. 10, 2024 (GLOBE NEWSWIRE) -- AmericaFirst Funds, a subsidiary of DSS, Inc. (NYSE American: DSS), today announced that effective August 9, 2024, David Friedensohn, Monica Himes and Alla...
DSS, Inc. Names Jason Grady as Interim Chief Executive Officer
NEW YORK, Aug. 26, 2024 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS) has announced the appointment of Jason Grady as its Interim CEO, effective August 23, 2024. Grady, who previously served as C...
Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled "Low Glycemic Sugar Composition."
NEW YORK, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Impact Biomedical Inc. (IBIO), in which DSS Inc.(NYSE American: DSS) has a significant investment, is thrilled to announce a milestone in its innovative Lae...
DSS, Inc. Chairman Chan Acquires 672,173 shares of DSS In Open Market
Chairman of the Board Heng Fai Ambrose Chan Adds 672,173 Shares to Increase Investment in Company Chairman of the Board Heng Fai Ambrose Chan Adds 672,173 Shares to Increase Investment in Company
DSS, Inc. Announces Reverse Split as Part of NYSE American Compliance Plan
NEW YORK, Dec. 22, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS, “Company”), a multinational company operating nine (9) diversified business lines developed through strategic acquisitions to...
Premier Packaging, a Wholly-Owned Subsidiary of DSS, Inc., Secures Contract Extension with Major Retailer Worth Up to $15 Million over Four Years
NEW YORK, Nov. 28, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a multinational company operating nine (9) diversified business lines developed through strategic acquisitions to build shar...
DSS, Inc. Subsidiary Files Current Report on Form 8-K Disclosing Reverse Split of Outstanding and Issued Common Stock and Conversion of Certain Holder's Common Stock
DSS Shareholders to Benefit from Reduction in Common Stock of Impact Biomedical DSS Shareholders to Benefit from Reduction in Common Stock of Impact Biomedical
DSS Inc. Receives Notice of Non-Compliance with NYSE American Trading Share Price Listing Rule
Company intends to cure the deficiency and return to compliance with NYSE American standard Company intends to cure the deficiency and return to compliance with NYSE American standard
DSS, Inc. Announces Filing of Registration Statement on Form S-1 for Initial Public Offering of Impact Biomedical
NEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) -- DSS, Inc.(NYSE American: DSS) ("DSS") announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commissio...
DSS Inc. Issues Letter to Shareholders
CEO Highlights Expected IPO of Impact Biomedical and Progress in Subsidiaries CEO Highlights Expected IPO of Impact Biomedical and Progress in Subsidiaries
DSS Inc. Expands DSS Wealth Management, Inc.'s Management Team for Ramp Up of Asset Management Subsidiary
Jim Monaghan Appointed Chief Operating Officer and Chief Compliance Officer; Michael Cheah Joins as Portfolio Manager and Head of Fixed Income Jim Monaghan Appointed Chief Operating Officer and Chief ...